(RTTNews) - Myriad Genetics, Inc. (MYGN), a genetic testing and precision medicine company, on Wednesday announced its groundbreaking study results on the Prequel Prenatal Screen with AMPLIFY ...

MYRIAD, the decentralized prediction market launched by Decrypt’s parent company DASTAN, launched on Abstract today, as the layer-2 blockchain’s mainnet went live. Following the launch, MYRIAD is one ...

Its new CEO is eyeing continued growth for the national pharmacy care management provider. A South Jersey company is starting the new year with a fresh name and a new leader. Tabula Rasa ...

Myriad Genetics, Inc. HOUSTON and SALT LAKE CITY, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...